CAS: 1338934-59-0
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | MKC8866 REF: TM-T15594CAS: 1338934-59-0 | 99.28% - 99.35% | 88,00 €~2.024,00 € | Mar 21 Ene 25 |
 | MKC8866 REF: IN-DA01EOOWCAS: 1338934-59-0 | 99% | A consultar | Mar 21 Ene 25 |
 | MKC8866 REF: 3D-NDC93459CAS: 1338934-59-0 | Min. 95% | 164,00 €~3.807,00 € | Jue 30 Ene 25 |
MKC8866
CAS:1338934-59-0
MKC8866, a selective IRE1 RNase inhibitor with an IC50 of 0.29 μM, curbs breast and …
Fórmula:
C18H19NO7
Pureza:
99.28% - 99.35%
Forma y color:
Solid
Peso molecular:
361.35
Ref: TM-T15594
| 1mg | 88,00 € | ||
| 5mg | 187,00 € | ||
| 10mg | 304,00 € | ||
| 25mg | 511,00 € | ||
| 50mg | 739,00 € | ||
| 100mg | 1.034,00 € | ||
| 500mg | 2.024,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
Ref: IN-DA01EOOW
| 1mg | 61,00 € | ||
| 5mg | 112,00 € | ||
| 10mg | 199,00 € | ||
| 25mg | 264,00 € | ||
| 50mg | 593,00 € | ||
| 100mg | A consultar | ||
| 250mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
MKC8866
CAS:1338934-59-0
MKC8866 is an experimental anti-cancer drug that is currently in Phase II clinical trials. It …
Fórmula:
C18H19NO7
Pureza:
Min. 95%
Forma y color:
Powder
Peso molecular:
361.35 g/mol
Ref: 3D-NDC93459
| 2mg | 294,00 € | ||
| 5mg | 583,00 € | ||
| 10mg | 999,00 € | ||
| 25mg | 2.115,00 € | ||
| 50mg | 3.807,00 € |
Entrega estimada en Estados Unidos, el Jueves 30 de Enero de 2025
